Comment to “Pregnancy and COVID-19, focus on vaccine and pharmacological treatment”
2022
Formats
| Format | |
|---|---|
| BibTeX | |
| MARCXML | |
| TextMARC | |
| MARC | |
| DublinCore | |
| EndNote | |
| NLM | |
| RefWorks | |
| RIS |
Files
Details
Title
Comment to “Pregnancy and COVID-19, focus on vaccine and pharmacological treatment”
Author(s)
Ceulemans, Michael (Clinical Pharmacology & Pharmacotherapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Belgium ; Teratology Information Service, Pharmacovigilance Centre Lareb, The Netherlands ; L-C&Y, KU Leuven Child & Youth Institute, Belgium)
Sillis, Laure (Clinical Pharmacology & Pharmacotherapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Belgium)
Foulon, Veerle (Clinical Pharmacology & Pharmacotherapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Belgium)
Panchaud, Alice (Service of Pharmacy, Lausanne University Hospital and University of Lausanne, Switzerland ; Institute of Primary Health Care (BIHAM), University of Bern, Switzerland)
Winterfeld, Ursula (Swiss Teratogen Information Service, Clinical Pharmacology Service, Lausanne University Hospital, Switzerland)
Pomar, Léo (Materno-Fetal and Obstetrics Research Unit, Lausanne University Hospital, Switzerland ; HESAV School of Health Sciences, HES-SO University of Applied Sciences and Arts Western Switzerland)
Cleary, Brian (Rotunda Hospital, Ireland ; School of Pharmacy, Royal College of Surgeons Ireland, Ireland)
O’Shaughnessy, Fergal (Rotunda Hospital, Ireland ; School of Pharmacy, Royal College of Surgeons Ireland, Ireland)
Passier, Anneke (Teratology Information Service, Pharmacovigilance Centre Lareb, The Netherlands)
Richardson, Jonathan Luke (UK Teratology Information Service, Newcastle upon Tyne Hospitals NHS Foundation Trust, UK)
Nordeng, Hedvig (Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Norway ; Department of Child Health and Development, Norwegian Institute of Public Health, Norway)
Sillis, Laure (Clinical Pharmacology & Pharmacotherapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Belgium)
Foulon, Veerle (Clinical Pharmacology & Pharmacotherapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Belgium)
Panchaud, Alice (Service of Pharmacy, Lausanne University Hospital and University of Lausanne, Switzerland ; Institute of Primary Health Care (BIHAM), University of Bern, Switzerland)
Winterfeld, Ursula (Swiss Teratogen Information Service, Clinical Pharmacology Service, Lausanne University Hospital, Switzerland)
Pomar, Léo (Materno-Fetal and Obstetrics Research Unit, Lausanne University Hospital, Switzerland ; HESAV School of Health Sciences, HES-SO University of Applied Sciences and Arts Western Switzerland)
Cleary, Brian (Rotunda Hospital, Ireland ; School of Pharmacy, Royal College of Surgeons Ireland, Ireland)
O’Shaughnessy, Fergal (Rotunda Hospital, Ireland ; School of Pharmacy, Royal College of Surgeons Ireland, Ireland)
Passier, Anneke (Teratology Information Service, Pharmacovigilance Centre Lareb, The Netherlands)
Richardson, Jonathan Luke (UK Teratology Information Service, Newcastle upon Tyne Hospitals NHS Foundation Trust, UK)
Nordeng, Hedvig (Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Norway ; Department of Child Health and Development, Norwegian Institute of Public Health, Norway)
Date
2022-08
Published in
Journal of reproductive immunology
Volume
August 2022, vol. 152, art.103639
Pagination
1 p.
ISSN
0165-0378
Article Type
scientifique
Faculty
Santé
Branch
Sage-femme
School
HESAV
Institute
Unité de recherche en santé, HESAV
Record Appears in